Prednisone News and Research

RSS
New strategy treats fatal autoimmune disease without outward off-target effects

New strategy treats fatal autoimmune disease without outward off-target effects

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

One-dose of dexamethasone can improve outcomes of asthmatic patients in ER

One-dose of dexamethasone can improve outcomes of asthmatic patients in ER

ZYTIGA plus prednisone provides overall survival benefit in men with early and less aggressive mCRPC

ZYTIGA plus prednisone provides overall survival benefit in men with early and less aggressive mCRPC

Positive bosutinib response for elderly blast phase CML patient

Positive bosutinib response for elderly blast phase CML patient

Innovative Phase II trial evaluates effectiveness of diabetes medication for lymphoma

Innovative Phase II trial evaluates effectiveness of diabetes medication for lymphoma

Phase 1 BelCHOP study shows belinostat and CHOP chemo regimen as first-line treatment for PTCL

Phase 1 BelCHOP study shows belinostat and CHOP chemo regimen as first-line treatment for PTCL

New drug combination shows promise in treating men with metastatic prostate cancer

New drug combination shows promise in treating men with metastatic prostate cancer

Giving antibiotics early can reduce risk of severe lower respiratory tract illness in children

Giving antibiotics early can reduce risk of severe lower respiratory tract illness in children

Aspen Park Pharmaceuticals acquires worldwide rights to APP-111 therapy from Ohio State University

Aspen Park Pharmaceuticals acquires worldwide rights to APP-111 therapy from Ohio State University

Health effects of occupational exposure to talc

Health effects of occupational exposure to talc

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

Mylan sued in connection with ANDA filing for generic version of Zytiga

Mylan sued in connection with ANDA filing for generic version of Zytiga

Endocrine Society recommends removal of tumor as first-line treatment for endogenous Cushing's syndrome

Endocrine Society recommends removal of tumor as first-line treatment for endogenous Cushing's syndrome

Rare BCR-ABL fusions highlighted in CML

Rare BCR-ABL fusions highlighted in CML

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Updated guidelines released for treatment of idiopathic pulmonary fibrosis

Updated guidelines released for treatment of idiopathic pulmonary fibrosis

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

Penn State dermatologist provides tips for treating poison ivy rash

Penn State dermatologist provides tips for treating poison ivy rash

OncoGenex's Phase 3 SYNERGY trial shows survival benefits of custirsen therapy in CRPC patients with poor prognosis

OncoGenex's Phase 3 SYNERGY trial shows survival benefits of custirsen therapy in CRPC patients with poor prognosis